<?xml version="1.0" encoding="UTF-8"?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.2/metadata.xsd">
  <identifier identifierType="DOI">10.5072/example</identifier>
  <creators>
    <creator>
      <creatorName nameType="Personal">Mari, Bernard</creatorName>
      <givenName>Bernard</givenName>
      <familyName>Mari</familyName>
    </creator>
    <creator>
      <creatorName nameType="Personal">Puissegur, Marie-Pierre</creatorName>
      <givenName>Marie-Pierre</givenName>
      <familyName>Puissegur</familyName>
    </creator>
    <creator>
      <creatorName nameType="Personal">Barbry, Pascal</creatorName>
      <givenName>Pascal</givenName>
      <familyName>Barbry</familyName>
    </creator>
    <creator>
      <creatorName nameType="Personal">Lebrigand, Kevin</creatorName>
      <givenName>Kevin</givenName>
      <familyName>Lebrigand</familyName>
    </creator>
  </creators>
  <titles>
    <title xml:lang="en">
      Identification of putative novel specific targets of mir-210 in A549 human adenocarcinoma cells
    </title>
  </titles>
  <publisher xml:lang="fr">
    Institut de Pharmacologie Moleculaire et Cellulaire (IPMC), CNRS UMR6097, Universite de Nice Sophia-Antipolis, 660 route des lucioles, 06560 Valbonne - Sophia-Antipolis, France
  </publisher>
  <publicationYear>2010</publicationYear>
  <subjects>
    <subject schemeURI="http://www.nlm.nih.gov/mesh/meshhome.html" subjectScheme="Mesh">Neoplasms</subject>
    <subject schemeURI="http://purl.obolibrary.org/obo/obi" subjectScheme="OBI">Transcription profiling</subject>
    <subject schemeURI="http://www.ncbi.nlm.nih.gov/Taxonomy/" subjectScheme="NCBITaxon">Homo sapiens</subject>
    <subject schemeURI="http://www.ebi.ac.uk/efo" subjectScheme="Mesh">A549</subject>
    <subject schemeURI="http://purl.obolibrary.org/obo/obi" subjectScheme="OBI">DNA microarray</subject>
  </subjects>
  <contributors>
    <contributor contributorType="HostingInstitution">
      <contributorName xml:lang="fr" nameType="Organizational">INIST-CNRS</contributorName>
    </contributor>
  </contributors>
  <language>en</language>
  <resourceType resourceTypeGeneral="Text">Experiment report</resourceType>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="URL" relatedMetadataScheme="ISA-Tab" relationType="HasMetadata" schemeType="Text" schemeURI="http://isatab.sourceforge.net/docs/ISA-TAB_release-candidate-1_v1.0_24nov08.pdf">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE18695</relatedIdentifier>
  </relatedIdentifiers>
  <sizes>
    <size>183 ko</size>
    <size>3 pages</size>
  </sizes>
  <formats>
    <format>PDF</format>
  </formats>
  <rightsList>
    <rights xml:lang="en-US" schemeURI="https://spdx.org/licenses/"   rightsIdentifierScheme="SPDX" rightsIdentifier="CC-BY-NC-ND-3.0"  rightsURI="http://creativecommons.org/licenses/by-nc-nd/3.0/"/>  </rightsList>
  <descriptions>
    <description xml:lang="en" descriptionType="Abstract">
      To identify putative novel specific targets of mir-210, we overexpressed miR-210 as well as miR-34a and a siRNA targeted against E2F3 in A549 human adenocarcinoma cells by transfecting them with synthetic pre-miRNAs or a synthetic negative pre-miRNA
      as control (miR-Neg). RNA samples were harvested at 48 hours post-transfection and 2 independent experiments performed in dye-swap: miR-210 versus miR-Neg ; miR-34a versus miR-Neg ; si-E2F3 versus miR-Neg ; si-control versus miR-Neg.
    </description>
  </descriptions>
</resource>
